Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,269 public trials 1,192 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer

NCT03088813

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • National Jewish Health Denver, Colorado, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Florida Cancer Specialists (South Region) Fort Myers, Florida, United States
  • Florida Cancer Specialists St. Petersburg, Florida, United States
View all 118 locations
View Trial Details
Completed

Afatinib in NSCLC With HER2 Mutation

NCT02597946

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Hunan Province Tumor Hospital Changsha, China
  • First Affiliated Hospital of Guangzhou Medical University Guangzhou, China
  • Zhejiang Cancer Hospital Hangzhou, China
  • The Second Affiliated Hospital to Nanchang University Nanchang, China
View Trial Details
Completed

Denosumab and Nivolumab Combination As 2d-line Therapy in Stage IV NSC Lung Cancer with Bone Metastases (DENIVOS)

NCT03669523

Conditions
Bone Metastases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • CH du Pays d'Aix Aix-en-Provence, France
  • Chu Angers Angers, France
  • Centre Hospitalier de Beauvais Beauvais, France
  • Centre Hospitalier Fleyriat Bourg-en-Bresse, France
View all 27 locations
View Trial Details
Completed

A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology.

NCT01346540

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • 1199.82.39004 Boehringer Ingelheim Investigational Site Milan, Italy
  • 1199.82.3102 Boehringer Ingelheim Investigational Site Maastricht, Netherlands
  • 1199.82.3401 Boehringer Ingelheim Investigational Site Barcelona, Spain
  • 1199.82.3406 Boehringer Ingelheim Investigational Site Madrid, Spain
View Trial Details
Completed

Intensified Chemo-immuno-radiotherapy With Durvalumab for Stage III Non-Small Cell Lung Cancers

NCT04230408

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • INCA Rio de Janeiro, Brazil
  • Liga Norte Riograndense Contra o Câncer Natal, Rio Grande do Norte, Brazil
  • CPO Porto Alegre, Rio Grande do Sul, Brazil
  • COI Américas Rio de Janeiro, Brazil
View Trial Details

Related conditions